Back
Soligenix Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Sell
31
SNGX
Soligenix
Last Price:
3.81
Seasonality Move:
-12.52%
Sell
26
LIXT
Lixte Biotechnology Holdings
Last Price:
1.89
Seasonality Move:
-12.11%
Sell
31
Soligenix (SNGX)
is a Sell
Is Soligenix a Buy, Sell or Hold?
- The current Soligenix [SNGX] share price is $4.01. The Score for SNGX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SNGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $2.00. The Score for LIXT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNGX Stock Price Chart
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $2.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.
SNGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 53.37 | Buy |
| Chaikin Money Flow: | 31839 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.37 - 4.27) | Buy |
| Bollinger Bands (100): | (3.18 - 6.08) | Sell |
LIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.95 | Sell |
| Chaikin Money Flow: | -12949 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.05) | Buy |
| Bollinger Bands (100): | (2.01 - 2.61) | Sell |
SNGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.6 | Buy |
| 20-day SMA: | 3.77 | Buy |
| 50-day SMA: | 4.4 | Sell |
| 200-day SMA: | 7.49 | Sell |
| 8-day EMA: | 3.69 | Buy |
| 20-day EMA: | 3.75 | Buy |
| 50-day EMA: | 4.1 | Sell |
| 200-day EMA: | 9.22 | Sell |
LIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2 | Buy |
| 20-day SMA: | 1.91 | Buy |
| 50-day SMA: | 2.1 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 2.01 | Sell |
| 20-day EMA: | 1.98 | Buy |
| 50-day EMA: | 2.09 | Sell |
| 200-day EMA: | 2.62 | Sell |
Soligenix Earnings Growth & SNGX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.00 per share, and an increase next year of $0.35 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Soligenix Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lixte Biotechnology Holdings Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||